AHL
ORGO icon

Abel Hall LLC’s Organogenesis Holdings ORGO Stock Holding History

Abel Hall LLC’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.8K Sell
11,500
-60,153
-84% -$118K ﹤0.01% 881
2026
Q2 		$174K Buy
+71,653
New +$175K 0.03% 767

Other funds holding ORGO

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
AP
Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CS
Capital Square Chattanooga, Tennessee $227M AUM 12.51% 1-Year Est. Return
SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Abel Hall LLC's ORGO Position: Q3 2026 in Review

Abel Hall LLC reduced its Organogenesis Holdings (ORGO) stake by 84% in Q3 2026, selling an estimated $118K and leaving 11,500 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #881.

Abel Hall LLC first reported a position in ORGO in Q2 2026 and has held it in 2 quarters since. The position peaked at $174K in Q2 2026. 12 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.

  • Abel Hall LLC held 11,500 shares of Organogenesis Holdings worth $15.8K as of Q3 2026.
  • Abel Hall LLC sold 60,153 Organogenesis Holdings shares in Q3 2026, an estimated $118K.
  • Organogenesis Holdings made up ﹤0.01% of Abel Hall LLC's portfolio in Q3 2026, its #881 holding.
  • Abel Hall LLC first reported a position in Organogenesis Holdings in Q2 2026 and has held it in 2 quarters since.
  • Abel Hall LLC's Organogenesis Holdings position peaked at $174K in Q2 2026.
  • 12 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.